Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

Dr. Hadi Shafiee, one of the lead researchers, explains, “Finding an HIV particle in human blood is like trying to find an ice cube in a jelly-filled Olympic pool while blindfolded.” ...

HIV holds on to the T helper cell and refuses to let go. The viral life cycle has begun, and one HIV particle will spawn a billion more.

Collab with Moderna This vaccine is supposed to be the first in a sequence of several doses, each conditioning the immune system with a distinct HIV particle. As the shots continue, the molecules ...

WASHINGTON, Sep 25, 2002 (United Press International via COMTEX) -- Researchers said recently that they can use specific bits of the deadly human immunodeficiency virus -- the organism that causes ...

The budded particle is shown at the center, now with a cutaway view of the inside of the HIV, which includes Gag proteins (yellowish orange) and Pol proteins (blue), which include enzymes needed ...

Researchers at CIDR, led by Yuntao Wu, professor in George Mason's School of Systems Biology and the principal investigator of the NIH-funded study, developed a special HIV-like virus particle ...

The cousin of HIV Obr and Schur first crossed paths while working on HIV-1 (Human Immunodeficiency Virus Type 1), aiming to better understand its structure. Obr then joined Schur's research group ...

An early trial for an experimental HIV vaccine candidate has shown promising results. 97% of recipients in a phase 1 study showed immune system activity in response to the vaccine.

These rafts--so named because they are insoluble in nonionic detergent--are domains within a cell membrane. The HIV glycosaminoglycan (Gag) proteins occupy these rafts. To build a new HIV particle, ...

Wu and his research team created a viral particle that is like HIV but genetically different. With this particle, they will inject it into the cells and destroy the HIV cells.